Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)
Clinical trial NCT02565992 · COMPLETED
Trial details
- NCT number
- NCT02565992
- Sponsor
- Viralytics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2019-11-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.